- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07827703
Effects of Digital Detox on Mental Health in Young Adults
Effects of Digital Detox on Mental Health in Young Adults: A Randomized Controlled Trial
The goal of this clinical trial is to learn whether a short, self-guided program for cutting down smartphone screen time can reduce symptoms of depression in young adults. It includes students in Oslo, Norway, who have applied for help at the student mental health service (SiO Mental Health).
The main questions it aims to answer are:
- Does a 2-week screen time reduction program reduce symptoms of depression?
- Does it reduce symptoms of anxiety?
- Can a simple, widely available phone app reduce screen time, and does the reduction last?
Researchers will compare students who start the program right away with students who continue their usual care for 2 weeks and receive the same program afterwards. Participants are placed in one of the two groups by chance, like flipping a coin.
Participants will:
- Answer questionnaires about depression and anxiety symptoms at the start and again after 2 weeks
- Upload screenshots of the Screen Time summary on their iPhone at the start, after 2 weeks, and after 12 weeks
- Install an app that blocks the apps they find most distracting and keep it active for 2 weeks, if they are placed in the program group
- Take part entirely online, with no clinic visits and no contact with the study team
Descripción general del estudio
Estado
Intervención / Tratamiento
Tipo de estudio
Inscripción (Estimado)
Fase
- No aplica
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Thomas Mildestvedt, Professor
- Número de teléfono: +47 55586163
- Correo electrónico: thomas.mildestvedt@uib.no
Ubicaciones de estudio
-
-
-
Oslo, Noruega
- Studentsamskipnaden i Oslo
-
Contacto:
- Thomas Mildestvedt, Professor
- Número de teléfono: +47 55586163
- Correo electrónico: thomas.mildestvedt@uib.no
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Has applied for care at SiO Mental Health, the student mental health service in Oslo, and has received the service's response to the application
- Owns an iPhone (the screen time restriction tool requires iOS)
- Able to understand written Norwegian
- Provides informed consent
Exclusion Criteria:
- None
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Cuidado como de costumbre
|
|
|
Experimental: Screen time reduction
|
Two-week self-guided use of an iOS screen time restriction app. Participants block their most distracting apps, with notifications disabled. Unlocking requires a 30-second delay, allows 10 minutes of access, then a 5-minute cooldown. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Symptoms of depression (PHQ-9)
Periodo de tiempo: From enrollment to the end of intervention at 2 weeks
|
Patient Health Questionnaire-9, range 0 to 27, higher scores indicate more depressive symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Total smartphone screen time
Periodo de tiempo: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Smartphone screen time by app category
Periodo de tiempo: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Number of daily smartphone pickups
Periodo de tiempo: 2 weeks and 12 weeks after randomization
|
2 weeks and 12 weeks after randomization
|
|
|
Symptoms of anxiety (GAD-7)
Periodo de tiempo: From enrollment to the end of intervention at 2 weeks
|
Generalized Anxiety Disorder-7, range 0 to 21, higher scores indicate more anxiety symptoms. |
From enrollment to the end of intervention at 2 weeks
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Self-reported changes in daily functioning and well-being
Periodo de tiempo: 2 weeks
|
Twelve single-item questions on perceived change over the past 2 weeks, each answered on a 5-point scale from 1 (much less than usual) to 5 (much more than usual). The domains are sleep, time spent with others, physical activity, time on other screens (computer, tablet), loneliness, satisfaction with oneself, rumination on negative thoughts, feeling of missing out, stress, ability to concentrate, satisfaction with own study effort, and getting done what one plans. Higher scores indicate more of the attribute than usual. Whether a higher score represents a better outcome depends on the domain. |
2 weeks
|
|
Adherence to the screen time restriction tool
Periodo de tiempo: 2 weeks
|
Self-reported proportion of the 2-week period with the blocking rule kept active, answered on a 5-level ordinal scale: all of the time, most of the time, part of the time, little of the time, none. Higher levels indicate greater adherence. Reported by the intervention group. |
2 weeks
|
|
Perceived usefulness and burden of the tool
Periodo de tiempo: 2 weeks and 12 weeks
|
Perceived usefulness of the tool for reducing screen time and perceived burden in everyday life, each answered on a 5-point scale from 1 (not at all) to 5 (to a very great extent), and a single question on intention to continue use (yes, no, do not know). Higher usefulness indicates a better outcome and higher burden a worse outcome. Reported by the intervention group at 2 weeks and by both groups at 12 weeks. |
2 weeks and 12 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Thomas Mildestvedt, Professor, University of Bergen
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Estimado)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 1000700
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Anonymized individual participant data underlying the published results.
Marco de tiempo para compartir IPD
After publication of the primary results.
Criterios de acceso compartido de IPD
Upon request to the principal investigator, under a data sharing agreement.
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
- SAVIA
- CIF
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .